Correspondingly, tumor cells enhance their antioxidant capacity by activating the Nrf2 pathway [57] and elevating cellular GSH levels to avoid cellular senescence, apoptosis, or ferroptosis induced by excessive ROS so as to allow tumor cells to adapt to and depend on high oxidative stress [36,58]. Here, NFE2L2 is linked to neoplasm.